Cargando…
Sustained Surface ICAM-1 Expression and Transient PDGF-B Production by Phorbol Myristate Acetate-Activated THP-1 Cells Harboring Blau Syndrome-Associated NOD2 Mutations
Objectives: Blau syndrome is a distinct class of autoinflammatory syndrome presenting with early-onset systemic granulomatosis. Blau syndrome-causing NOD2 mutations located in the central nucleotide-oligomerization domain induce ligand-independent basal NF-κB activation in an in vitro reporter assay...
Autores principales: | Nishiyama, Mizuho, Li, Hong-jin, Okafuji, Ikuo, Fujisawa, Akihiko, Ehara, Mizue, Kambe, Naotomo, Furukawa, Fukumi, Kanazawa, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145400/ https://www.ncbi.nlm.nih.gov/pubmed/33923123 http://dx.doi.org/10.3390/children8050335 |
Ejemplares similares
-
NOD2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination
por: Arakawa, Akiko, et al.
Publicado: (2021) -
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
por: Ueki, Yoko, et al.
Publicado: (2023) -
Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis
por: Matsuda, Tomoko, et al.
Publicado: (2022) -
Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome
por: Chang, Shao-Yu, et al.
Publicado: (2022) -
Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome
por: Ikeda, Kei, et al.
Publicado: (2014)